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Dengue virus (DENV) is a mosquito-borne virus that has four serotypes. Collection of serum from patients is time-
and labor- consuming, and presents a high injury risk for infants and children. The genomic and serological
diagnosis of imported dengue fever from a urine sample was used as a non-invasive diagnostic method in this
study. A serum sample was collected on disease day 5, and a serum and urine sample were collected on disease
day 8 and 18. The results of serological tests for DENV IgM revealed that the serum samples were positive for DENV.
The results of RT-qPCR assay revealed that the serum sample collected on day 5 was DENV-positive; however, the
serum sample collected on day 8 and 18 were negative for DENV. The urine sample collected on day 8 and 18 were
DENV-positive. We also sequenced the complete DENV genome (10723 bp) from the urine sample (GenBank
KF479233). The results of phylogenetic and epidemiological analysis indicated strong confirmation that the strain
was located within the DENV-2 group with a 100% bootstrap value. In this report, we (1) provided the first evidence
of a DENV infection that was imported from India to a non-endemic city of China, (2) investigated the DENV
genome detection having a longer timeframe for positive detection in urine sample compared to previous studies,
(3) provided the sequence results for the complete DENV-2 genome from a concentrated urine sample (4) discussed
how virus-typing results could be used to manage the risk of sero-specific and re-infected travel-associated
dengue fever.
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Dengue virus (DENV) has four different serotypes and
any one of related types will cause dengue infection with
the main transmission of mosquitoes [1]. DENV infec-
tion with one serotype may drive the development of
dengue hemorrhagic fever (DHF) or dengue shock syn-
drome (DSS) after re-infection with another serotype,
which has a high mortality rate (1–2.5%) [2]. To prevent
re-infection, it is important to detect the primary DENV
serotype infection in travelers returning from highly en-
demic areas. The laboratory DENV diagnoses include viral* Correspondence: hukongxin@caiq.gov.cn
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unless otherwise stated.isolation, viral antigen detection, antibody detection and
genomic test. The combination of serological tests and
RT-qPCR is an approach that is often to confirm DENV
infection [3]. Laboratory diagnostic detections in health
examination for international travelers usually need pa-
tients’ serum as detecting samples. However, collection of
serum sample is time- and labor-consuming, presents a
high injury risk for infants and children, and depends on
patients’ compliance. Several studies have reported that
DENV genome detection in urine is an alternative non-
invasive diagnostic method, and the timeframes for posi-
tive detection in urine are longer than they are in serum
[4-6]. Considering the severe DENV secondary infection,
the DENV long-last timeframe in urine sample provides a
monitoring chance rather than the serological test to de-
tect positive DENV infection with the identification of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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frame for positive detection of dengue virus in urine sam-
ples than previous studies have reported. In addition to
the difficulties of patients’ serum collection, the weakness
of serological test is a high risk of the cross-reaction with
other flaviviruses such as Yellow Fever Virus (YFV) [7].
The complete DENV genome provides a strong molecular
evidence to determine dengue virus and its serotype. Here,
this case report first represents the diagnosis and seroty-
ping of a case of imported dengue fever from the urine
sample and provide the full genome sequence of this
DENV-2 at a point of entry in North China.
Case presentation
A 47-year-old businessman who resided in Qinhuangdao,
Hebei Province, China, visited India, and then returned
home. Domestic DENV infection does not occur in
Qinhuangdao, which is located at 39° north latitude
(Figure 1). In Asia, the geographical distribution of
DENV infection is between 25° north latitude and 25°
south latitude, and is concentrated in south central and
Southeast Asia (Figure 1) [8].
The patient had no previous medical history of dengue
fever or renal disease, and had not received Japanese en-
cephalitis or yellow fever vaccines. He visited Chennai,
India, for 5 days, from Dec 18 to Dec 22 2013, and ar-
rived in Qinhuangdao on Dec 23. The patient recalled
that he had been bitten by mosquitoes sometime bet-
ween Dec 19 and Dec 22. If disease day is defined as the
time of the fever onset, he developed fever (37.5–39.5°C),
arthralgia, retro-orbital pain, waist pain, and abdominal
pain on Dec 27 (disease day 0). His clinical examinationFigure 1 Location of the case report. Qinhuangdao: the home city of th
supplied by MATLAB®.data were: fever (39.2°C); face exanthema; white blood cell
count, 3.8 × 109/L (reference range, 4–10 × 109/L); platelet
count, 31 × 109/L (reference range, 100–300 × 109/L); and
urine protein +++. He had no previous history of renal
disease, blood urea nitrogen, creatinine, β2-microglobulin
levels, and urinalysis results were within normal limits
from Dec 27, 2013 to Jan 14, 2013. No apparent renal
dysfunction was present. By Jan 4, 2013 (day 8), his
headache, waist pain, and abdominal pain subsided, and
no rashes or hemorrhage were present. There was no
bleeding or bruising under the skin, and no pachye-
mia, or hepatomegaly.
As soon as the results of the clinical and epidemiolo-
gical investigations indicated the presence of an impor-
ted infectious disease, the hospital notified the bureau.
Serum and urine samples were collected on Dec 27,
2012 to Jan 14, 2013, stored at −80°C and sent to our la-
boratory. The RNA samples were extracted from a 5 mL
urine sample and were ultracentrifuged at 303800 RCF
(BECKMAN COULTER® Optima L-100 XP ultracentri-
fuge, Fullerton, CA, USA) for 2 hours at 4°C. The total
RNA from 140 μl serum and urine samples were ex-
tracted separately using the QIAamp Viral RNA Mini kit
(QIAGEN, Valencia, CA, USA). The RNA was eluted in
60 μl elution buffer and stored at −80°C. The singleplex
RT-qPCR was performed using an Applied Biosystems®
7500 real-time PCR system (Applied Biosystems® by Life
Technologies, Carlsbad, CA, USA) to test the DENV
conservative region at 3′UTR. The DENV-specific pri-
mers and Taqman probes were designed by previous study
[9] (Table 1). The RT-qPCR reagents were carried out by
AgPath-ID™ One-Step RT-PCR Kit (Ambion, Appliede patient; Chennai: the travel destination of the patient. Image
Table 1 Nucleotide sequence of primers and probe used in the RT-qPCR assay*
Sequence Nucleotide position
Forward primer 5′-FAM-GARAGACCAGAGATCCTGCTGTCT-3′ 10635–10658
Reverse primer 5′-FAM-ACCATTCCATTTTCTGGCGTT-3′ 10708–10682
TaqMan MGB probe 5′-FAM-AGCATCATTCCAGGCAC-3′ 10663–10679
*: [9].
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RT-qPCR mixture included 12.5 μl 2X RT-PCR Buffer,
1 μl 25X RT-PCR Enzyme Mix, 0.5 μl one-step RT-PCR
Master Mix (Qiagen), 0.5 μl (20 μM ) of each primer,
0.3 μl (10 μM ) probe, 4.7 μl nuclease-free water and 5 μl
extracted RNA. The thermocycling parameters were: re-
verse transcription (RT) at 45°C for 10 min, RT inactiva-
tion at 95°C for 10 min and fluorescence detection for
40 cycles of 95°C for 15 s and annealing at 60°C for 45 s.
The RT-qPCR data was analyzed using the SDS software
provided by Applied Biosystems®. Amplification curves
were evaluated by the threshold line placed over the back-
ground signal, and intersecting the initial exponential
phase of the curve. Amplification of DENV was observed
at a quantification cycle (Cq) value of 28. The serological
tests for DENV IgM provided in a commercial ELISA kit
(Panbio® Dengue IgM Capture ELISA, Sinnamon Park,
Australia) were tested from disease day 0 to 18. The NS1
antigen colloidal gold test was carried out using the CIK
DENV OnSite Rapid Test® (CTK Biotech, Inc, San Diego,
CA, USA). This test was used first as the most rapid
diagnostic tool to identify dengue virus. However, the
immunochromatographic card test usually has a low spe-
cificity and sensitivity compared with molecular methods
and ELISAs. The results were consistent with the conclu-
sions of previous studies that demonstrated the compared
clinical diagnostic methods [10-12]. The results of the
assays were presented in Table 2. The Qinhuangdao Entry-
Exit Inspection and Quarantine Bureau advised the patient
about future travel in dengue high risk regions before his
discharge from the hospital on Jan 15, 2013.
The viral RNA was reverse transcribed using the re-
verse primer with AMV reverse transcriptase (Promega
Corporation, Madison, WI, USA). The reverse transcrip-











2012-12-27 0 NT + + NT
2013-1-1 5 NT + + NT
2013-1-4 8 + − − −
2013-1-14 18 + − − −
NT: No Test; + Positive; − Negative.conventional PCR amplification covering the full gen-
ome with 16 sets of DENV specific primers succeeded in
cDNA template. Amplified products were detected using
agarose gel electrophoresis and sequence identification.
The sequencing was performed using an ABI PRISM
3730 DNA Sequencer. Overlapping sequencing fragments
were assembled to generate a contiguous full-genome se-
quence (10723 bp) using Lasergene (DNASTAR, Madison,
WI, USA). The complete DENV genome was submitted
to GenBank (accession number KF479233).
The assembled sequence isolated from the patient’s
urine was aligned with NCBI BLASTn default parameter
against the non-redundant nucleotide database (nr/nt).
An E-value of 0 was used as the cutoff. The cutoff of the
query coverage and the identity were >99% and >95%
above, respectively. The result indicated that all query
hits were dengue virus type 2, but the hits were variant
strains from different South Asian countries.
A phylogenetic analysis of the DENV envelope gene
(E gene) coding sequence (1485 bp) was performed by
comparing the KF479233 strain with 14 other E gene se-
quences isolated from four South Asian countries that
were obtained from the NCBI GenBank database. The
coding sequences were analyzed to make a neighbor-
joining tree with 1000 bootstrap replications, which was
created using MEGA5 (Tempe, AZ USA) software [13].
After the phylogenetic analysis, DENV-2 strains were sep-
arated from the DENV-1, DENV-3, and DENV-4 clades
(Figure 2). The KF479233 strain was strongly located
within the DENV-2 group, as indicated a high bootstrap
value (100%).
Conclusions
Besides the early clinical diagnosis at the onset of symp-
toms, our results indicated that urine sample analysis
was a noninvasive diagnostic approach, and the time-
frames for positive detection in urine were longer than
that in serum [6]. Serum samples can have a high de-
tection rate (>50%) in the first week after the onset of in-
fection. However, the last positive detection of virus in
serum samples was no later than disease day 11. Urine
sample detection rates can be >50% between disease day
6 to 16, with the last positive detection of virus on day
16 [6]. In this case, our data were consistent with pre-
vious studies that reported a longer timeframe of posi-
tive detection (Table 2). The full DENV-2 genome was
Figure 2 Neighbor-joining phylogenetic tree based on dengue virus: DENV-1, DENV-2, DENV-3, and DENV-4. Each taxon indicates a
single E gene coding sequence and is labeled with the origin, collection year, and GenBank accession numbers. Boldface taxon label represents
the E gene coding sequence from DENV complete genome isolation from a urine sample with the GenBank accession number KF479233.
Numbers on each branch represent the bootstrap values.
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was the longest timeframe reported for DENV positive
detections. Based on the results of previous studies, the
application of DENV detection from urine samples has
an important future role for a fast, accurate and nonin-
vasive diagnosis [4,6,14].
Data on the geographical and phylogenetic relatedness
of DENV strains provide further evidence on between-
country transmission of imported strains. Phylogenetic
analysis provided strong evidence to confirm that the
sample was associated with the DENV type 2 India group.
The most similar strain to the KF479233 strain was iso-
lated in Singapore (bootstrap values, 100%), and indicated
that imported from India [15]. The second closest strain
to the KF479233 strain was isolated in India in 2009
(JN568258.1); it has been confirmed as an imported case
in Australian residents returning from India [16]. DENV-2
was emerged as the prominent serotype outbreaks in
Chennai, Tami Nadu, from the 1970s to the 2000s
(Figure 1) [17]. The high endemic DENV outbreaks were
mostly observed during the rainy season (Oct to Dec) in
Chennai, which coincided with the time of travel for the
patient in this report [18]. The phylogenetic and epi-
demiological analysis confirmed that the KF479233 sero-
type was the DENV-2 imported from India.
DENV infection can develope into two types of clinical
illness, dengue fever and more severe DHF or DSS. The
first single serotype infection will result in a lifelong im-
munity to the infecting serotype. During a heterotypic
DENV secondary infection, the cross-reactivity will en-
hance DENV replication and may cause severe DHF or
DSS. Although secondary infection by any of the DENV
serotypes may cause a severe symptom, not all infectionspresent the same risk for severe development. Early stu-
dies of DHF in Thailand suggested that secondary DENV-
2 infection was 5–7 times more frequent compared with
secondary DENV-1, DENV-3 or DENV-4 infection [19].
As the co-circulation of multiple DENV serotypes in en-
demic dengue areas, in cases of international travelers,
there are more chances of exposure to a cross-reacting
transmitted DENV infection. The identification of DENV
serotypes present in a primary infection will provide a
clear description of the clinical diagnosis for clinicians,
and play an important role as an evidence supports
for understanding of the mechanism of DHF/DSS and
the research of cross-reactivity of different serotype
antibodies in a secondary infection. As the recent re-
search and studies reported, there is still no vaccine
against DENV and no medications to treat a dengue
infection. The prevention will be the most important
step, and it means avoiding mosquito bites if re-traveling
to an dengue endemic area. The dengue serotype-
specific risk needs to monitor against re-infection on
the pre-traveling advice for international travelers who
will stay in dengue high risk regions in the future
traveling.
In this report, we (1) provided the first evidence of
a DENV infection that was imported from India to a
non-endemic city of China, (2) investigated the DENV
genome detection having a longer timeframe for posi-
tive detection in urine sample compared with previ-
ous studies, (3) provided the sequence results for the
complete DENV-2 genome from a concentrated urine
sample, and identified DENV-2 by comparing it to iso-
lates from nearby geographic areas, (4) discussed me-
dical advice on the risk of sero-specific and re-infected
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results.
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